Intec Pharma Ltd. (NASDAQ: NTEC) ("Intec" or "the Company") today announces top-line data from the Company's pivotal Phase 3 trial ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Corporate News FDA Hot Corp. News Hot FDA News Management Comments Trading Halts

Maxim Group Downgrades Intec Pharma Ltd. (NTEC) to HoldJuly 22, 2019 11:13 AM Intec Pharma (NTEC) to Resume Trading at 7:30 am ETJuly 22, 2019 7:25 AM Intec Pharma Reports Top-Line Phase 3 Trial Results of Accordion Pill-Carbidopa/Levodopa in Advanced Parkinson's Disease PatientsJuly 22, 2019 7:00 AM Intec Pharma (NTEC) Halted, News PendingJuly 22, 2019 6:56 AM